On April 13, Han Qide, the former vice chairman of the National Committee of the Chinese People's Political Consultative Conference, went to Wanbangde Group to inspect. Fang Fangming, member of the Standing Committee of the Zhejiang Provincial Committee of the Chinese People's Political Consultative Conference, vice chairman of the Jiusan Society Provincial Committee, and vice president of Zhejiang University School of Medicine, Zheng Fang, secretary of the party group and vice chairman of the Zhejiang Association for Science and Technology Jin Ping, Jiang Changcai, Vice Chairman of Zhejiang Association for Science and Technology, Chen Weiyi, Chairman of Taizhou Political Consultative Conference, Li Lifei, Vice Chairman of Taizhou Municipal Political Consultative Conference, Wang Zongming, Mayor of Wenling City, and Zhao Shouming, Chairman of Wanbangde Group, were accompanied.

Han Qide successively inspected the industrial layout sand table and product exhibition hall of Wanbangde Group. Zhao Shouming introduced to Han Qide that Wanbangde Group has comprehensively deepened reform through system and mechanism innovation, focused on strategic emerging industries such as medicine and medical equipment, optimized the industrial layout, and deeply cultivated the four major industries of pharmaceutical industry, aluminum industry, medical device industry and bearing industry in Wenling. Business sector, to build Wanbangde big health industry cluster. Aiming at the international market, the group actively "brings in", actively "goes out", integrates domestic and foreign R&D resources, conquers key core technologies, and focuses on the development of innovative drugs, high-end generic drugs, high-end medical devices, new materials, and high-end bearings. At present, Huperzine A, Ginkgo Leaf Dropping Pills, and various types of aluminum profile products have a relatively large market share in China. Han Qide nodded and said: "Scientific and technological innovation is the core of enterprise development. Only by making breakthroughs in key areas and key links can enterprises maintain their vitality forever."

In the pharmaceutical industry product exhibition hall, Han Qide had an in-depth understanding of the innovative research and development of drugs and the consistency evaluation of generic drugs. After learning that the Alzheimer's disease drug Huperzine A injection, which is researched and developed by the National Academician Expert Workstation of Wanbangde Group, has been approved for production, the national exclusive variety Ginkgo Biloba Dropping Pill with independent intellectual property rights has been included in the The 2018 National Key R&D Program—“Research on Modernization of Traditional Chinese Medicine”—Key Special Project—Research on the Quality Standards of Large Varieties of Chinese Patent Medicines Registered in the European Union (Project No.: 2018YFC1707905), after many new varieties are about to be launched, Han Qide said that Wanbangde Group should seize the New opportunities in the pharmaceutical market under the background of an aging society, to promote the industrialization of Huperzine A products, and to speed up the internationalization of products with independent intellectual property rights. He also emphasized that in addition to attaching importance to the research and development of targeted innovative drugs, it is also necessary to increase the development and investment of generic drugs with great market potential and high clinical value, so as to form a brand advantage, strengthen and expand the biopharmaceutical industry, and take root in China to the world.

During the inspection, Han Qide also learned in detail about the product types of implantable medical devices of Wanbangde Group and the introduction of industrialization technology. Han Qide pointed out that Wanbangde Group has been at the forefront of high-quality development through the three-step strategy of overseas mergers and acquisitions, domestic integration, and product internationalization.

Before getting on the car, Han Qide specifically warned that high-end medical devices, as a national strategic emerging industry, have strong market demand, but the domestic R&D innovation level is low and core technologies are few. In the process of promoting the localization of medical devices, it is necessary not only to transfer and transform the industrialization technology of South Africa, but also to introduce "bioengineering + biomedicine" cross-complex cross-border talents, introduce 3D printing technology, research and development and production to fill the domestic gap and replace imports. high-end products, further improve product quality and benefit human health.

Han Qide (second from right), former vice chairman of the National Committee of the Chinese People's Political Consultative Conference, visited Wanbangde Group